BACKGROUND	In a recent study in normal-weight adults , the 6-wk intranasal administration of the MSH/ACTH ( 4-10 ) core fragment of proopiomelanocortin resulted in a distinct reduction of body weight and body fat , accompanied by significant decreases in leptin and insulin plasma concentrations .\